“Two names stand out in the pharma space at this point of time; one is Sun Pharma and the other one is Dr Reddy’s. The rest of the companies have corrected but there are challenges either on the generic pricing front or their own product specific issues. We are not really going very aggressive on the midcap side of pharma.”
Subscribe To Our Free Newsletter |